MedTrace Logo

Gong's Mobilization and Sustained Natural Apophyseal Glide in Office Workers With Cervical Spine Overload

NCT05021458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-04-22

No results posted yet for this study

Summary

Neck pain is a frequent and disabling complaint in the general population. One of the most common causes of neck pain is mechanical dysfunction of the cervical spine. Although diverse methods have been proposed for increasing cervical range of motion (ROM), joint mobilization has been confirmed as effective in several studies. Typically, joint mobilization methods for increasing cervical ROM include spinal manipulative therapy, the activator and diversified techniques. There are different mobilization techniques for neck pain, and mulligan's technique is one of them. It has two techniques Sustain Natural Apophyseal Glides (snags) and Natural Apophyseal Glides (nags). Gong's mobilization technique helps to heal physical pain as well as distract the mind from stress. In this study, the effectiveness of gong's mobilization and Sustained Natural Apophyseal Glides (snags) will be compared in office workers who have problems with cervical posture and range of motion (ROM) in order to examine the effects of gong's mobilization on cervical pain and cervical ROM. Twenty office workers with problems of cervical posture, pain and ROM is divided into a gong's mobilization group (n=10) and a Snags group (n=10). Gong's mobilization and nags will be administered three times a week for four weeks to each respective group and then changes in cervical posture, pain and cervical ROM will be evaluated.

Conditions

  • Cervical Spine Sprain

Interventions

OTHER

Gong's mobilization

Ten patients will be treated with Gong's mobilization.

OTHER

SNAG

: Ten patients will be treated with SNAGs

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Muhammad Salman Bashir, PhD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-05
Primary Completion
2022-01-30
Completion
2022-03-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05021458 on ClinicalTrials.gov